These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37353100)
1. Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy. Aly S; El-Kamel AH; Sheta E; El-Habashy SE Int J Pharm; 2023 Jul; 642():123163. PubMed ID: 37353100 [TBL] [Abstract][Full Text] [Related]
2. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma. Pandey V; Gajbhiye KR; Soni V Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582 [TBL] [Abstract][Full Text] [Related]
3. Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia. Abou-Elnour FS; El-Habashy SE; Essawy MM; Abdallah OY Biomater Adv; 2024 Sep; 162():213924. PubMed ID: 38875802 [TBL] [Abstract][Full Text] [Related]
4. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC. Jain A; Sharma T; Kumar R; Katare OP; Singh B Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178 [TBL] [Abstract][Full Text] [Related]
5. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
6. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line. Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934 [TBL] [Abstract][Full Text] [Related]
8. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer. Wang W; Chen T; Xu H; Ren B; Cheng X; Qi R; Liu H; Wang Y; Yan L; Chen S; Yang Q; Chen C Molecules; 2018 Jun; 23(7):. PubMed ID: 29966245 [TBL] [Abstract][Full Text] [Related]
9. Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells. Halder A; Jethwa M; Mukherjee P; Ghosh S; Das S; Helal Uddin ABM; Mukherjee A; Chatterji U; Roy P Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1362-1371. PubMed ID: 33284038 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511 [TBL] [Abstract][Full Text] [Related]
11. Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapy. Atallah MA; Sallam MA; Abdelmoneem MA; Teleb M; Elkhodairy KA; Bekhit AA; Khafaga AF; Noreldin AE; Elzoghby AO; Khattab SN Colloids Surf B Biointerfaces; 2022 Sep; 217():112657. PubMed ID: 35803031 [TBL] [Abstract][Full Text] [Related]
12. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line. Kostrzewa T; Nowak I; Feliczak-Guzik A; Drzeżdżon J; Jacewicz D; Górska-Ponikowska M; Kuban-Jankowska A Int J Nanomedicine; 2023; 18():2507-2523. PubMed ID: 37197025 [TBL] [Abstract][Full Text] [Related]
13. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation. Kuo YC; Cheng SJ Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730 [TBL] [Abstract][Full Text] [Related]
14. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Zheng G; Zheng M; Yang B; Fu H; Li Y Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925 [TBL] [Abstract][Full Text] [Related]
15. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724 [TBL] [Abstract][Full Text] [Related]
16. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Garg NK; Singh B; Jain A; Nirbhavane P; Sharma R; Tyagi RK; Kushwah V; Jain S; Katare OP Colloids Surf B Biointerfaces; 2016 Oct; 146():114-26. PubMed ID: 27268228 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma. Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers. Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692 [TBL] [Abstract][Full Text] [Related]
19. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells. da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731 [TBL] [Abstract][Full Text] [Related]
20. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Pindiprolu SKSS; Krishnamurthy PT; Dev C; Chintamaneni PK Chem Phys Lipids; 2021 Mar; 235():105033. PubMed ID: 33385372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]